Sensivida, a developer and provider of minimally invasive diagnostic technologies and devices, published on its website a letter to shareholders sent on September 22, 2010. 

The Letter summarizes important recent advances in the Company’s product development, business strategy, fund raising, and an expanded management team.

The full Letter to Shareholders follows and is available at www.sensividamedical.com.